Jing Liang
University of Helsinki(FI)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Immune Cell Function and Interaction, RNA Research and Splicing, Protein Degradation and Inhibitors, Epigenetics and DNA Methylation
Most-Cited Works
- → IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect(2011)200 cited
- → Expression of VLDLR in the Retina and Evolution of Subretinal Neovascularization in the Knockout Mouse Model’s Retinal Angiomatous Proliferation(2008)127 cited
- → Preclinical activity of a novel multiple tyrosine kinase and aurora kinase inhibitor, ENMD‐2076, against multiple myeloma(2010)49 cited
- → Neuropeptide Y‐Mediated Gut Microbiota Alterations Aggravate Postmenopausal Osteoporosis(2023)43 cited
- → Synergistic Activity of Bendamustine in Combination with Doxorubicin and Bortezomib in Multiple Myeloma Cells(2008)8 cited
- → Enhancing Natural Killer (NK) Cell Mediated Killing of Non-Hodgkin's Lymphoma.(2009)8 cited
- → Clinical Activity of a Novel Multiple Tyrosine Kinase and Aurora Kinase Inhibitor, ENMD-2076, Against Multiple Myeloma: Interim Phase I Trial Results(2010)6 cited
- → CDK9 inhibition activates innate immune response through viral mimicry(2024)6 cited
- → Dynamically Quantifying Intracellular Elemental Sulfur and Predicting Pertinent Gene Transcription by Raman Spectroscopy in Living Cells(2023)5 cited
- → IPH2101, a Novel Anti-Inhibitory KIR Monoclonal Antibody, and Lenalidomide Combine to Enhance the Natural Killer (NK) Cell Versus Multiple Myeloma (MM) Effect.(2009)4 cited